StockDrifts LogoStockDrifts

SLS Bio 246250

Company
에스엘에스바이오SLS Bio
Insiders
1
Buys
1
Total Value
₩25M ($17K)
Avg Return
-13.15%
Last Filing
2025-03-10

SLS Bio (246250) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩25M ($17K) in reported transaction value. The earliest filing StockDrifts holds for SLS Bio is dated 2024-06-28; the most recent is 2025-03-10. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is -13.15%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-03-10SELL증여
문해란
What is literacy?
--100.0K₩1,658-18.8%₩166M ($115K)
2025-03-10SELL증여
문해란
What is literacy?
--50.0K₩1,658-18.8%₩83M ($58K)
2025-03-10SELL증여
문해란
What is literacy?
--100.0K₩1,658-18.8%₩166M ($115K)
2025-03-10SELL증여
문해란
What is literacy?
--100.0K₩1,658-18.8%₩166M ($115K)
2025-03-10SELL증여
문해란
What is literacy?
--20.0K₩1,658-18.8%₩33M ($23K)
2025-03-10SELL증여
문해란
What is literacy?
--30.0K₩1,658-18.8%₩50M ($35K)
2025-03-10SELL증여
문해란
What is literacy?
--20.0K₩1,658-18.8%₩33M ($23K)
2025-03-10SELL증여
문해란
What is literacy?
--30.0K₩1,658-18.8%₩50M ($35K)
2024-07-15BUY무상신주취득
이영태
Youngtae Lee
CEO1.2M₩2,780-29.2%₩3.2B ($2.2M)
2024-07-15BUY무상신주취득
문해란
What is literacy?
-1.0M₩2,780-29.2%₩2.8B ($2.0M)
2024-07-15BUY무상신주취득
김종수
Jongsu Kim
Other non-executive directors2.0K₩2,780-29.2%₩6M ($4K)
2024-07-15BUY무상신주취득
김봉휘
Kim Bong-hwi
Director of Research Institute33.0K₩2,780-29.2%₩92M ($64K)
2024-06-28BUYMarket Buy
이영태
Youngtae Lee
CEO10.9K₩2,267-13.2%₩25M ($17K)

Frequently asked questions

Who has been buying SLS Bio stock?
1 distinct insiders have filed 1 disclosed insider purchases in SLS Bio (246250), most recently on 2025-03-10. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does SLS Bio have?
SLS Bio has 1 buy-side and 0 sell-side disclosures on record, covering ₩25M ($17K) in total reported value, spanning 2024-06-28 to 2025-03-10.
Where does StockDrifts get SLS Bio insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for SLS Bio. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.